1498. Geographic differences in weight change on dolutegravir: a prospective cohort study

BACKGROUND: People with HIV (PWH) on integrase inhibitors may be at increased risk of excess weight gain, but it is unclear if this risk is consistent across settings. Our study objective was to compare weight change over 48 weeks among PWH in Uganda and South Africa. [Figure: see text] METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Geoffrey, Migisha, Richard, Muyindike, Winnie R, Aung, Taing N, Nanfuka, Victoria, Komukama, Nimusiima, Chandiwana, Nomathemba, Shazi, Gugulethu, Moosa, Mahomed-Yunus S, Gupta, Ravindra K, Pillay, Deenan, Marconi, Vincent, Hedt-Gauthier, Bethany, Francois Venter, W D, Siedner, Mark J, McCluskey, Suzanne M, Manne-Goehler, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678982/
http://dx.doi.org/10.1093/ofid/ofad500.1333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678982/
http://dx.doi.org/10.1093/ofid/ofad500.1333

Ejemplares similares